Nuvation Bio Dividende
Zukünftiges Wachstum Kriterienprüfungen 0/6
Nuvation Bio does not have a record of paying a dividend.
Wichtige Informationen
n/a
Dividendenausschüttung
-0.3%
Rückkaufsrendite
| Gesamte Aktionärsrendite | -0.3% |
| Zukünftige Dividendenrendite | n/a |
| Wachstum der Dividende | n/a |
| Nächster Dividendenzahlungstermin | n/a |
| Ex-Dividendendatum | n/a |
| Dividende pro Aktie | n/a |
| Ausschüttungsquote | n/a |
Aktuelle Dividendenentwicklung
Keine Aktualisierungen
Recent updates
Nuvation Bio: Competitive Data In ROS1+ NSCLC, Strong Cash, Smallish Market
Oct 21Nuvation Bio: Continuing To Justify A Buy Thesis With Catalysts In 2024
Aug 08Is Nuvation Bio (NYSE:NUVB) A Risky Investment?
Aug 07
Nuvation Bio: A Potentially Transformative Acquisition
Jun 20Nuvation Bio: Strong Buy Off The Acquisition Of A Late-Stage Lung Cancer Candidate
Mar 31Nuvation: Cash Is King, Science Is An Afterthought
Oct 03We Think Nuvation Bio (NYSE:NUVB) Can Afford To Drive Business Growth
Sep 14Seth Klarman's Baupost adds Herbalife, Altice USA, exits Dropbox, Enhabit
Feb 14We're Hopeful That Nuvation Bio (NYSE:NUVB) Will Use Its Cash Wisely
Feb 10We Think Nuvation Bio (NYSE:NUVB) Can Afford To Drive Business Growth
Nov 09Nuvation Bio GAAP EPS of -$0.12 beats by $0.02
Nov 03Stabilität und Wachstum des Zahlungsverkehrs
Rufe Dividendendaten ab
Stabile Dividende: Insufficient data to determine if NUVB's dividends per share have been stable in the past.
Wachsende Dividende: Insufficient data to determine if NUVB's dividend payments have been increasing.
Dividendenrendite im Vergleich zum Markt
| Nuvation Bio Dividendenrendite im Vergleich zum Markt |
|---|
| Segment | Dividendenrendite |
|---|---|
| Unternehmen (NUVB) | n/a |
| Untere 25 % des Marktes (US) | 1.5% |
| Markt Top 25 % (US) | 4.5% |
| Branchendurchschnitt (Pharmaceuticals) | 2.3% |
| Analystenprognose (NUVB) (bis zu 3 Jahre) | n/a |
Bemerkenswerte Dividende: Unable to evaluate NUVB's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
Hohe Dividende: Unable to evaluate NUVB's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Gewinnausschüttung an die Aktionäre
Abdeckung der Erträge: Insufficient data to calculate NUVB's payout ratio to determine if its dividend payments are covered by earnings.
Barausschüttung an die Aktionäre
Cashflow-Deckung: Unable to calculate sustainability of dividends as NUVB has not reported any payouts.